US8523123052 - Common Stock
STAA stock results show that Staar Surgical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Staar Surgical (NASDAQ:STAA) just reported results for the first quarter of 202...
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
The company makes an implantable lens to help correct vision problems.
These three alternatives to Nvidia stock combined are smaller than the chipmaker but are worth it when considering Nvidia's market cap.
STAAR Surgical announces strategic agreement with SharpeVision to offer EVO ICL lenses as a preferred option for vision correction, increasing availability...
Here are just a few of the top stocks with strong insider buying that all investors may want to watch heading into 2024.